Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy

Osman Şevket; Seda Ates; Gokhan Kılıc; Taner Molla; Fulya Ozkal; Ramazan Dansuk; Sefa Kelekci

TR EN

Gebelik sırasında Oral Glukoz Tolerans Testi ihtiyacını azaltmak için açlık kan şekeri kullanımı

Abstract

Amaç: Gestasyonel diabetes mellitus (GDM) tanısı için gerekli Oral glukoz tolerans testi (OGTT) sayısını sınırlamak için açlık plazma glikozun (APG) kullanımı değerlendirmektir. Gereç ve yöntem: Tahmini gebelik yaşları 24-28 hafta arasında 390 gebe GDM açısından değerlendirildi. Tanı için OGTT’e dayalı International Association of Diabetes and Pregnancy Study Group (IADPSG) kriterleri kullanıldı. İki APG eşik değeri GDM’ nin ekarte edilmesi ve dahil edilmesi için kullanıldı. Bulgular: Katılımcıların 61 (%15.6)’i GDM tanısı aldı. GDM tespit etmek için kullanılan APG’nin ROC eğrisi altında kalan alan 0.933 oldu. GDM tanısı için APG’nin ≥5.1mmol/ eşik değer kullanıldığında sensitivite %70.49 ve spesifite %100.00 oldu. APG’nin ≤4.5 mmol/l eşik değer kullanıldığında sensitivite %93.44 ve spesifite %67.60 oldu. Başlangıç APG’nin kullanılması OGTT ihtiyaçını %67,7 oranında azalmaktadır ve sadece %1,5’i yanlış sınıflandırılmaktadır. Sonuç: GDM tanısı için AFP’nin alt ve üst eşik değerlerinin kullanılması OGTT ihtiyacını azaltmaktadır. Bu yöntemle GDM hastalarının hemen hemen tümü tanınabilmektedir.

Keywords

GDM tanısı, açlık plazma glukoz, OGTT

Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy

Abstract

OBJECTIVE: Since introduction of antiretroviral therapy (ART), HIV-related mortality has decreased and quality of life in HIV/AIDS patients has improved. ART is quite complicated due to side effects, drug interractions, adherence and drug resistance problems. In this study, we aimed to determine the side effects related to ART among HIV/AIDS patients followed by our Outpatient Clinic. METHODS: HIV/AIDS patients followed by the Infectious Diseases and Clinical Microbiology HIV/AIDS Outpatient Clinic between January 2006 and December 2011 were included in this study. Medical records were reviewed to determine the prevalence of side effects, causes and results in HIV/AIDS patients on ART.RESULTS: Of 260 HIV/AIDS patients 171(%65.7) were under ART. Of these, number of patients with ART related side effects 123 (%72). The most frequent side effects were neuropsychiatric complications (%30.4), diarrhea (%9.3) and hyperlipidemia (%16.9). ART regimen was changed in 13 (%7.6) of the patients had ART related side effects.CONCLUSION: The prevalence of ART related side effects are common and it may decrease drug adherence. Hence, close monitoring of ART toxicities in HIV/AIDS patients on ART assumes great importance.

Keywords

HIV/AIDS, antiretroviral therapy, side effects

References

No references found

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Osman Şevket This is me

Seda Ates This is me

Gokhan Kılıc This is me

Taner Molla This is me

Fulya Ozkal This is me

Ramazan Dansuk This is me

Sefa Kelekci This is me

Publication Date

October 1, 2013

Submission Date

October 1, 2013

Acceptance Date

-

Published in Issue

Year 2013 Number: 3

IZ

https://izlik.org/JA49ZE72US

APA

Şevket, O., Ates, S., Kılıc, G., Molla, T., Ozkal, F., Dansuk, R., & Kelekci, S. (2013). Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy. Pamukkale Medical Journal, 3, 122-126. https://izlik.org/JA49ZE72US

AMA

1.Şevket O, Ates S, Kılıc G, et al. Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy. Pam Med J. 2013;(3):122-126. https://izlik.org/JA49ZE72US

Chicago

Şevket, Osman, Seda Ates, Gokhan Kılıc, et al. 2013. “Using an Initial Fasting Plasma Glucose to Decide the Need for the Oral GlucoseTolerance Test During Pregnancy”. Pamukkale Medical Journal, nos. 3: 122-26. https://izlik.org/JA49ZE72US.

EndNote

Şevket O, Ates S, Kılıc G, Molla T, Ozkal F, Dansuk R, Kelekci S (October 1, 2013) Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy. Pamukkale Medical Journal 3 122–126.

IEEE

[1]O. Şevket et al., “Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy”, Pam Med J, no. 3, pp. 122–126, Oct. 2013, [Online]. Available: https://izlik.org/JA49ZE72US

ISNAD

Şevket, Osman - Ates, Seda - Kılıc, Gokhan - Molla, Taner - Ozkal, Fulya - Dansuk, Ramazan - Kelekci, Sefa. “Using an Initial Fasting Plasma Glucose to Decide the Need for the Oral GlucoseTolerance Test During Pregnancy”. Pamukkale Medical Journal. 3 (October 1, 2013): 122-126. https://izlik.org/JA49ZE72US.

JAMA

1.Şevket O, Ates S, Kılıc G, Molla T, Ozkal F, Dansuk R, Kelekci S. Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy. Pam Med J. 2013;:122–126.

MLA

Şevket, Osman, et al. “Using an Initial Fasting Plasma Glucose to Decide the Need for the Oral GlucoseTolerance Test During Pregnancy”. Pamukkale Medical Journal, no. 3, Oct. 2013, pp. 122-6, https://izlik.org/JA49ZE72US.

Vancouver

1.Osman Şevket, Seda Ates, Gokhan Kılıc, Taner Molla, Fulya Ozkal, Ramazan Dansuk, Sefa Kelekci. Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy. Pam Med J [Internet]. 2013 Oct. 1;(3):122-6. Available from: https://izlik.org/JA49ZE72US

Pamukkale Medical Journal is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC).

Gebelik sırasında Oral Glukoz Tolerans Testi ihtiyacını azaltmak için açlık kan şekeri kullanımı

Abstract

Keywords

Using an initial fasting plasma glucose to decide the need for the Oral GlucoseTolerance Test during pregnancy

Abstract

Keywords

References

Details

Primary Language

Subjects

Journal Section

Authors

Publication Date

Submission Date

Acceptance Date

Published in Issue

IZ

Cite